Abingworth

Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.

1 review
Add your review

Independent rating of Abingworth VC fund

Overall rating:
1 review
Team quality
Not reviewed
Professionalism
None
Personal qualities
None
Integrity
None
Respect and decency
None
Experience
None
Relevant expertise
None
Investment process
Not reviewed
Approachability
None
Clarity of the process
None
Speed of the process
None
Responsiveness
None
Ease of the process
None
Due diligence
None
Value add
Not reviewed
Supportiveness
None
Value add beyond financing
None
Board activity
None
Terms
None
Founder friendly
None
Help with follow-up rounds
None

About Abingworth VC fund

Website:
http://www.abingworth.com
Founded:
1973
Number of funds:
6
Number of investments:
164
Number of exits:
75
Headquarters:
London, United Kingdom
Organization type:
Venture Capital

How Abingworth VC fund invests

Rounds:
Post, Series B, Series A, Series C
Average ticket size:
24.1M USD
Smallest investment:
5.2M USD
Biggest investment:
49.1M USD
Would lead round:
Yes
Would coinvest:
Yes
Countries where invested:
United States, Latvia, Canada, Switzerland
Sectors of interest:
Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical, Life Science, Clinical Trials, Biopharma

Portfolio - latest investments by Abingworth VC fund
CymaBay Therapeutics
Scorpion Therapeutics
Effector Therapeutics
Anjarium Biosciences
Jasper Therapeutics
Wugen
Vera Therapeutics
Adaptate Biotherapeutics
X4 Pharmaceuticals
Glycomine

Founders' reviews of Abingworth VC fund

Not reviewed
Team quality
Not reviewed
Investment process
Not reviewed
Value add
Not reviewed
Older than a year by non-portfolio founder
Smart, Fair and Good to Work With
Very smart group; extensive contacts in the UK and Europe; willingness to invest in early-stage companies/technologies (in the life science space); highly recommend them
Similar funds